Charted
Wednesday, Nov. 18, 2026The business of health, by the numbers
Live trackersDeal tracker $7.07B raisedFDA clearances 293 510(k)s in OctoberForm D raises $839M in 30 daysNew trials 266 Phase 2/3 in 30 days
Payers & Policy·CVS Health

CVS lifts adjusted 2026 outlook to at least $8.20 as insurance unit's profit nearly triples

CVS Health's insurance segment cut its medical benefit ratio to 91.3% from 92.8% and nearly tripled adjusted operating income, and the company raised its adjusted 2026 EPS guidance to at least $8.20.

From CVS Health's third-quarter 2026 earnings release, furnished to the SEC on Form 8-K Nov. 4, 2026
A CVS Pharmacy store in Oakland, Calif.
A CVS Pharmacy store in Oakland, Calif. File photo.Thomasfan1916 / Wikimedia Commons (CC BY-SA 4.0)

CVS Health's insurance business is doing most of the lifting this year.

CVS said Nov. 4 that the medical benefit ratio in its Health Care Benefits segment fell to 91.3% in the third quarter from 92.8% a year earlier, and the segment's adjusted operating income rose to $912 million from $314 million, according to its earnings release. The company raised its 2026 adjusted earnings guidance to at least $8.20 a share from a range of $7.90 to $8.10.

Why it matters: CVS described the segment's results as continued execution of a margin recovery plan, and the nine-month figures show its size: the segment's medical benefit ratio was 87.8% through September, compared with 90.0% a year earlier, and its adjusted operating income rose to $6.38 billion from $3.62 billion. Even so, CVS said it is keeping a cautious view for the rest of the year because cost trends remain elevated and macroeconomic headwinds are possible.

Total revenue rose 5.4% to $108.4 billion. GAAP diluted earnings were $1.68 a share, compared with a loss of $3.13 a year earlier, when CVS recorded a $5.7 billion goodwill impairment. Adjusted earnings were $2.09 a share, up from $1.60, and adjusted operating income rose 21.2% to $4.19 billion.

GAAP guidance moved to at least $6.98 a share from $6.84 to $7.04, which the company also described as an increase. CVS raised its outlook for cash flow from operations to at least $15.5 billion from at least $11.5 billion, after generating $15.3 billion through September. It expects full-year revenue of at least $420 billion.

Inside the margin recovery

Health Care Benefits revenue rose 2.4% to $36.9 billion, which CVS attributed to growth in its government business, partly offset by its 2026 exit from the individual exchange market. The company said better underlying results in the government business drove both the lower medical benefit ratio and the higher income. Over the first nine months, its estimates of what it owed for care in prior years proved $1.3 billion too high.

Medical membership was 26.1 million at Sept. 30, unchanged from June 30 and down from 26.7 million a year earlier.

The exchange exit sets CVS apart from Centene, which still had 3.4 million Marketplace members at the end of September.

Pharmacy businesses

Revenue in the Health Services segment, which includes the pharmacy benefit manager, rose 9.5% to $54.0 billion, driven by drug mix and brand inflation and partly offset by price improvements for pharmacy clients, the company said. Adjusted operating income rose 2.7% to $2.11 billion on better purchasing economics and drug mix, and pharmacy claims processed rose 1.3%.

Pharmacy & Consumer Wellness revenue fell 2.0% to $35.5 billion, which CVS attributed to regulation-driven price cuts on some drugs, new generic introductions and reimbursement pressure. The segment's adjusted operating income rose 10.6% to $1.64 billion, helped by core pharmacy performance and the Rite Aid assets it acquired in the third quarter of 2025.

"Through their continued dedication, each of our businesses delivered another quarter of strong results," David Joyner, chairman and chief executive, said in the release.

CVS said more than 69% of Aetna's Medicare Advantage members are enrolled in plans with four or more stars for 2027, similar to the at least 69% that UnitedHealthcare reported for its members in October. Those ratings, which CMS published Oct. 8, will affect 2028 quality bonus payments. The release did not include a 2027 earnings outlook.

Sara Montes de Oca is the Editor in Chief of Charted. She previously worked as a correspondent and producer in Washington, D.C., covering business, finance, and politics. Drafted with automated tools from the sources listed with this story and checked against them before publishing. How we report.

More Payers & Policy

More
Newsletter

Charted Daily

The day's deals, FDA decisions and policy moves, by the numbers. Free. Sign up now to get the first edition.

No spam. Unsubscribe any time.